Chest Journal Podcasts

Donald Robert McCaffree, MD, MSHA, Master FCCP, and Neeraj R. Desai, MD, MBA, FCCP, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the tobacco industry's deceptive communications to the public and the government.

James D. Chalmers, MD, PhD, and Ian D. Pavord, FMedSci, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to debate if inhaled corticosteroids should be withdrawn in patients with in GOLD 3 COPD.

Peter J Mazzone, MD, MPH, FCCP, and Renda Soylemez Wiener, MD, MPH, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss updated recommendations for lung cancer screening.

Wesley H. Self, MD, MPH, and editorialist Michael S. Niederman, MD, FCCP, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the paper by Self et al, which discusses the clinical significance of radiologic signs of pneumonia visualized on a CT scan but not concurrently seen on a chest x-ray.

Jose L. Cardenas-Garcia, MD, and Seth J. Koenig, MD, FCCP, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to debate whether all initial episodes of hemoptysis should be evaluated by bronchoscopy.

Matthew C. Miles, MD, FCCP, and Rendell W. Ashton, MD, FCCP, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss strategies for success in fellowship. This is the first article in the new CHEST section Teaching, Education, and Career Hub (TEaCH).

Jennifer K. Quint, PhD, and editorialist Michael C. Steiner, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the observational analysis of recorded referral for pulmonary rehabilitation in relation to subsequent healthcare utilization for acute exacerbation of COPD.    

Ariane Lewis, MD, and Robert D. Troug, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to offer their thoughts from their Point/Counterpoint editorials on whether informed consent should be required for apnea testing in patients with suspected brain death.

Athol U. Wells, MD, and Joshua J Mooney, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to debate whether bronchoalveolar lavage should be a standard diagnostic tool for IPF. The discussion centers on the lack of evidence-based agreement on the value of performing BAL.

Anand Padmanabhan, MD, PhD, and editorialist Theodore Warkentin, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the paper by Padamanabhan et al, which describes outcomes in three patients with heparin-induced thrombocytopenia (HIT) who responded well to IVIg therapy.

Nichole T. Tanner, MD, MSCR, FCCP, and editorialist Jonathan M. Iaccarino, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the accuracy of physician assessment in predicting malignancy in pulmonary nodules. Although adept at recognizing the pretest probability of malignancy, physicians would provide better patient care if they had followed guideline-recommended next steps in evaluation.

Mark J. Zucker, MD, JD, FCCP, and Anne R. Hemnes, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to review the pros and cons of their Point/Counterpoint debate, “Should Wireless Pulmonary Artery Hemodynamic Monitoring Be Used to Monitor Patients With Pulmonary Hypertension?”

Paul E. Marik, MD, FCCP, and Editorialist Heleen M. Oudemans-van Straaten, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss Dr. Marik and colleagues' retrospective study of the effectiveness in treating patients with severe sepsis and specific shock with the early use of intravenous vitamin C, together with corticosteroids and thiamine.

Ahmed H. El-Sherief, MD, and editorialist Galit Aviram, MD, join CHEST podcast editor, D. Kyle Hogarth, MD, FCCP, to discuss the study by Dr. El-Sherief and others on the inconsistencies in lymph node classification and the need for a lymph node map that simultaneously communicates a standard set of lymph node station definitions in three languages—using the language of anatomic landmarks for surgeons, bronchoscopic landmarks for pulmonologists, and visual CT landmarks for radiologists.

Gregory A. Schmidt, MD, FCCP, and Pierre Kory, MD, join CHEST podcast editor, D. Kyle Hogarth, MD, FCCP, to discuss their Point/Counterpoint debate on the value of inferior vena cava ultrasound to determine the use of acute fluid resuscitation for patients in shock.

Chanu Rhee, MD, MPH, and Robert C. Hazy, MD, FCCP, join CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to review and analyze the results of Dr. Rhee et al's research estimating incidences and mortality of septic shock over a ten-year period. Their results showed that the incidence has risen but mortality rates have fallen.

Brian Funaki, MD, and Mark L. Lessne, MD, joint CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss this month's Point/Counterpoint debate: Do the Benefits Outweigh the Risks for Most Patients Under Consideration for Inferior Vena Cava Filters?

Alain Tremblay, MD, and editorialist David E. Ost, MD, FCCP, joined CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the research by multi-center Canadian study by Tremblay et al that evaluated how well autofluorescence bronchochoscopy (AFB) detected high-grade lesions in patients at risk for lung cancer. Their study determined that too few CT occult cancers were detected to justify its addition into a lung cancer screening program.

Devanand Anantham, MD, and Ching-Fei Chang, MD, join CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to discuss the multi-country Asian adaption of guidelines to evaluate pulmonary nodules.

Anand Padmanabhan, MD, joins David A. Garcia, MD, FCCP, and guest podcast moderator, Bruce L. Davidson, MD, FCCP, to discuss the results of the research of Dr. Padmanabhan et al on a PF4-dependent platelet activation assay to identify patients likely to have heparin-induced thrombocytopenia/thrombosis.